Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have earned an average rating of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective […]